|
|
![]() |
L2WS:LabToWallStreet would like to thank our
sponsors and partners for their support. If you are interested in advertising, becoming a sponsor, or partnering with L2WS, please visit the
Partner with L2WS page for detailed information and/or contact us at
advertise@labtowallstreet.com.
Sponsors
 | Stroock & Stroock & Lavan LLP, established in 1876, is a law firm providing transactional and litigation guidance to leading multinational corporations, investment banks, and venture capital firms in the U.S. and abroad. Stroock's emphasis on client service and innovation has made it one of the nation's leading law firms for 125 years. Stroock's practice areas include corporate finance, legal services to financial institutions, energy, financial restructuring, intellectual property, litigation and real estate.
From protecting and enforcing a client's intellectual property rights, to devising alternative solutions for raising capital, Stroock is a valuable choice for biotechnology companies as they experience market and business cycles. Biotech companies take advantage of our multidisciplinary skills in intellectual property, litigation, private placements, tax issues and planning, and venture capital investments. | | |
Media Partners
 | BioSpace is globally recognized as the leading provider of web-based resources and information to the life science industry. For 20 years BioSpace has helped to accelerate communication and discovery among business and scientific leaders in the biopharmaceutical market. With a well-established site infrastructure and loyal online audience of over 1.5 million unique monthly visitors, BioSpace.com offers an unparalleled distribution channel for recruitment, investment, product, event and other life science industry messages.
| | |  | ExL Pharma, a division of ExL Events, Inc., is an emerging leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community. | | |  | International Business Forum is the leading presenter of venture
capital and private equity conferences in the United States. For over 15 years, IBF has been presenting conferences that unite investors to discuss current investing trends and discuss investing strategies. IBF produces conferences on the following venture capital subjects: Venture Capital Investing, Early Stage Investing, Later Stage Investing, Corporate Venturing & Strategic Partnering, Biotech & Life Sciences Investing, Medtech Investing, Nanotech Investing and Intellectual Property Commercialization & Spinouts conferences. International Business Forum was founded in 1989. | | |  | IXPERION - Six Sigma Conferences is the principal conference company focusing exclusively on Six Sigma and related quality initiatives. Our mission is to provide high-end, specialized Six Sigma events, designed for an international audience that is closely define by interest and profession.
We present discussion platforms to the rapidly expanding Six Sigma community and investigate the latest Quality challenges including:
• Integration of Six Sigma with existing quality initiatives
• The role of TRIZ in Six Sigma
• Financial analysis and ROI for Six Sigma
• Design for Six Sigma in manufacturing and non-manufacturing environments
• Six Sigma at Internet speed
• Establish a Six Sigma culture throughout the organization
• Reliable data collection paramount to successful Six Sigma program
| | |  | The Strategic Research Institute creates, produces and manages
conferences covering industry specific business-to-business topics.
Our globally recognized events provide powerful business research,
education and information, which relates directly to market trends,
global competition and technological change.
These conferences also provide a forum for face-to-face networking
between industry leaders, potential strategic partners, prospects and
customers. The subject matter, target audience, and market acceptance of each Strategic Research Institute conference is thoroughly researched by a team of experts. This ensures that the most pertinent information will be disseminated to the appropriate audience.
Our mission is to provide relevant and strategically focused
information at professionally managed events.
With headquarters in New York City, and branch office in Los Angeles,
Strategic Research Institute is dedicated to providing cost effective, highly specialized information in the format of conferences, workshops, and industry-wide events.
For more information, please visit http://www.srinstitute.com | | |
Institutional/
Organizational Partners
 | LILSI's mission is to attract, retain and develop life sciences companies in the pharmaceutical, biotechnology, medical device, nutriceutical and cosmeceutical sectors on Long Island by providing business development, strategic networking, and educational opportunities to enhance corporate competitiveness, productivity, efficiency and profitability. LILSI is focused on creating a nurturing business environment that comprehensively supports the life sciences community on Long Island by working to address issues of strategic importance to the long-term growth and sustainability of the life sciences sector in the region. LILSI represents the interests of the local life sciences industry through program development and government relations activities that maintain a clear visionary focus while creating a dynamic and highly interactive life sciences community. In this way, LILSI has profound potential to significantly impact the regional economy and quality of life by supporting companies that will develop and produce powerful diagnostic tools, targeted therapeutic interventions, and innovative technologies to assist, augment, and enhance our lives. | | |  | The Center for Biotechnology was established in 1983 as a cooperative research and development partnership between universities, private industry, and New York State. Its goal has been to capitalize on the resources of New York's medical biotechnology research for the purpose of fueling economic development in New York State. The Center for Biotechnology’s mission is to capitalize upon the resources of the Stony Brook University for the purpose of economic development in New York State. A cornerstone of the Center’s success has been its investment in the establishment of a broad-based infrastructure that supports entrepreneurial activity and industry growth. Center-driven initiatives have included the establishment of the Long Island High Technology Incubator (LIHTI) program, founding of the New York Biotechnology Association (NYBA) and the Long Island Life Sciences Initiative (LILSI), and the creation of an Innovative Technology Development (ITD) Program focused on the discovery and development of academic-based technologies toward commercial goals. | | |
L2WS Supports!
 | The Iacocca Foundation was founded in 1984 by Lee Iacocca in memory of his late wife, Mary K. Iacocca, who died of diabetic complications in 1983. The primary purpose of the Iacocca Foundation is to fund innovative and promising diabetes research programs and projects that will lead to a cure for the disease and alleviate complications caused by it.
| | |
|
|
